Financials
Financial year 2025
BIOVEST from Gent, company number BE0458022914, closed financial year 2025 with a result of € 6.9 million after tax. For that financial year BIOVEST recorded a gross margin of € -45,227 and equity of € 34.8 million. Compared with financial year 2024, the result moved from € -197,962 to € 6.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 34.8 million
▲ 25% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6.9 million
▲ still € 197,962 loss in 2024
Profit after tax over the fiscal year.
€ 3 million
▲ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 45,000 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,140
▲ 134% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -64,144 | € -58,830 | € -43,603 | € -45,227 | ▼ € 1,624 |
| Profit after taxes | € 9,244,036 | € 4,818,379 | € -197,962 | € 6,926,192 | ▲ € 7.1 million |
| Equity | € 38,749,222 | € 33,567,601 | € 27,869,639 | € 34,750,831 | ▲ 25% |
| Total debts | € 7,508,167 | € 6,505,387 | € 6,504,469 | € 1,054,789 | ▼ 84% |
| Cash | € 4,525,081 | € 5,581,774 | € 2,636,848 | € 3,011,075 | ▲ 14% |
| Retained profit | € 13,699,222 | € 8,517,601 | € 2,819,639 | € 9,700,831 | ▲ 244% |
| Dividend | € 10,000,000 | € 10,000,000 | € 5,500,000 | € 45,000 | ▼ 99% |
| Balance sheet total | € 46,257,389 | € 40,072,988 | € 34,374,108 | € 35,805,620 | ▲ 4% |
Key figures of BIOVEST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOVEST?
What happened at BIOVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6.9 million. Source: NBB ↗
- RMM Services NV became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 9.2 million profit in 2022 to € 6.9 million profit in 2025.
Paid € 653,964 in corporate taxes since 2022.
Best year ever: 2022, with € 9.2 million profit.
Paid out € 25.5 million in dividends to the owners in total.
Management
Behind BIOVEST is RMM Services NV. It owns 37.5% of Obelisc NV, 10% of Cenosco CO-Investment and 1.7% of Bonsai NV itself.
Directors
According to the 2025 annual accounts
Director · represented by Stefan Mariën
Also active at: ARGON, Bio-Incubator Gent 2, BIOSCAPE B, BIOSCAPE C, BIOSCAPE A, MENAPY, The Real Factory, OBELISC +6 more
since 2020
Establishments
Establishment units
Physical locations of this company
Karel van de Woestijnestraat 1-3
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0458.022.914
- VAT number
- BE 0458.022.914
- Registered office
- Karel van de Woestijnestraat 1-3, 9000 Gent
- Names & denominations
- BIOVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 May 1996
- Peppol
- Active · Active since 6 Jan 2026